Hepatic amebiasis: experience in the therapy of 56 cases.
DOI:
https://doi.org/10.20344/amp.3911Abstract
The results of therapy in 56 consecutive cases of hepatic amebiasis are reviewed. In retrospect, the results in patients receiving metronidazole alone, dehydroemetine combined with chloroquine, and dehydroemetine combined with chloroquine and metronidazole were compared. No deaths occured. Our results confirm the great efficacy of metronidazole alone. The response to treatment was similar in patients receiving dehydroemetine combined with chloroquine but the average number of days of hospitalization was greater in these patients. No advantage was demonstrated for the combination of metronidazole with dehydroemetine and chloroquine. In retrospect these patients proved to have a more severe and protracted course with more frequent surgical complications and a greater need for closed aspiration of the abscess. Closed aspiration, not used routinely, has not reduced the number of days of hospitalization. Significant side effects were not observed.
Downloads
Downloads
How to Cite
Issue
Section
License
All the articles published in the AMP are open access and comply with the requirements of funding agencies or academic institutions. The AMP is governed by the terms of the Creative Commons ‘Attribution – Non-Commercial Use - (CC-BY-NC)’ license, regarding the use by third parties.
It is the author’s responsibility to obtain approval for the reproduction of figures, tables, etc. from other publications.
Upon acceptance of an article for publication, the authors will be asked to complete the ICMJE “Copyright Liability and Copyright Sharing Statement “(http://www.actamedicaportuguesa.com/info/AMP-NormasPublicacao.pdf) and the “Declaration of Potential Conflicts of Interest” (http:// www.icmje.org/conflicts-of-interest). An e-mail will be sent to the corresponding author to acknowledge receipt of the manuscript.
After publication, the authors are authorised to make their articles available in repositories of their institutions of origin, as long as they always mention where they were published and according to the Creative Commons license.
